AUTHOR=Vedala Krishna , Sobash Philip , Shah Parth , Kamoga Gilbert-Roy 

TITLE=Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?

JOURNAL=Frontiers in Public Health

VOLUME=9

YEAR=2021

URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2021.670941

DOI=10.3389/fpubh.2021.670941

ISSN=2296-2565

ABSTRACT=<p><italic>Clostridioides difficile</italic> infection possesses a significant economical burden, specifically in the inpatient and rural settings. Fecal Microbiota Transplant has been used for treatment of recurrent <italic>Clostridioides difficile</italic> but its utility is limited by current guidelines and resources. We conducted a retrospective chart review to evaluate the financial benefit of using Fecal Microbiota Transplant after first recurrence of <italic>Clostridioides difficile</italic> infection. We found that while its use was restricted, on average Fecal Microbiota Transplant can save $11,603.49 per patient. In conclusion, our study shows that using Fecal Microbiota Transplant could prove to be economically beneficial in treating recurrent CDI in rural hospitals.</p>